DM

Devki Mulchandani

Active Director Director DIN 10700245
DIN 10700245 First appointment Jul 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Devki Mulchandani

Data last updated:

Devki Mulchandani is a Director at Eternal-Medicare Private Limited (since 2024). Eternal-Medicare Private Limited reported revenue of ₹3.2 Lakh (FY 2025).

DIN 10700245
Primary Designation Director
First Appointment 09 Jul 2024
Oldest Company Age 2 yrs
Largest company Eternal-Medicare Private Limited · ₹3.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eternal-Medicare Private Limited U46497DL2024PTC433934
Director09 Jul 20242024₹3.2 Lakh (FY 2025)Active

Board colleagues of Devki Mulchandani

NameDINCompanyDesignation
Sunil Kumar Subnani10700244Eternal-Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eternal-Medicare Private Limited
Premium access

Shareholding and investment profile for Devki Mulchandani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devki Mulchandani

Devki Mulchandani currently holds 1 directorship: Eternal-Medicare Private Limited (Director, since 09 Jul 2024, revenue ₹3.2 Lakh (FY 2025)).

Devki Mulchandani was first appointed on 09 Jul 2024 as Director at Eternal-Medicare Private Limited.

The current boards of Devki Mulchandani's companies include Sunil Kumar Subnani (Eternal-Medicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available